Fact CheckerSign in

NCT04797364Active, not recruiting

Pharmacogenetic Supported Prescribing in Kids

Source: ClinicalTrials.gov · Last updated 12 May 2026

Brief summary (registry, in English)

Implementation of pharmacogenetic testing for children and adolescents aged 6-24 who are starting or changing psychiatric medication.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
6000 (estimated)
First submitted
9 Mar 2021
Start date
18 Jan 2021
Primary completion date
1 Oct 2026
Lead sponsor
University of Calgary
NCT number
NCT04797364

What you commit to

  • Study type: Interventional
  • Planned participants: 6000
  • From 18 Jan 2021 to the primary completion date, 1 Oct 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of liver or bone marrow (hematopoietic cell) transplant

Other

  • Medically unstable or lacking capacity to provided informed consent
  • Unwillingness of child to provide saliva sample for genetic analysis

Who the study is looking for

  • Medical records available
  • The initiation, change, dose adjustment, or augmentation of psychiatric medication(s) is indicated
  • Treating psychiatrist, family physician, or pediatrician licensed in Alberta, British Columbia, Saskatchewan, or Manitoba requests pharmacogenetic testing

Age in the registry: 6 years to 24 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Of Calgary
Coordinator of this site? Confirm its status		CalgaryCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.